Document:

Exhibit 10.6

 

EXECUTION
COPY

 

PLACEMENT
AGENCY AGREEMENT

 

December
10, 2021

 

Univest
Securities LLC

Investment Banking

375
Park Avenue, 15th Fl.

New
York, New York 10152

 

Ladies
and Gentlemen:

 

Subject
to the terms and conditions herein (this “Agreement”) and the Transaction Documents (defined below), Marizyme, Inc.,
a Nevada (the “Company”), hereby agrees to sell units consisting of secured convertible promissory notes in the aggregate
principal amount of up to eighteen million ($18,000,000 DOLLARS in the form attached as Exhibit A (the “Note”),
together with class C warrants (“Warrants”) to purchase shares of common stock, par value $0.001 per share (the “Common
Stock”), of the Company (the “Warrant Shares”) directly to one or more investors (each, an “Investor”
and, collectively, the “Investors”) through Univest Securities LLC (the “Placement Agent”), as
placement agent. The Securities (as defined below) shall be offered and sold pursuant to Section 4(a)(2) under the Securities Act of
1933, as amended (the “Securities Act”). The documents executed and delivered by the Company and the Investors in
connection with the Offering (as defined below), including, without limitation, a unit purchase agreement (the “Purchase Agreement”),
the Note, the Warrants, and a security agreement shall be collectively referred to herein as the “Transaction Documents.”
The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the
Offering (as defined below). The Units, including the Notes and the shares of Common Stock issuable upon conversion of the Notes (the
“Conversion Shares”), the Class C Warrants and the Warrant Shares are hereafter collectively referred to as the”Securities.”

 

The
Company hereby confirms its agreement with the Placement Agent as follows:

 

Section
1. Agreement to Act as Placement Agent.

 

(a)
On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agent shall be the exclusive Placement Agent in connection with the offering and sale by the Company
of the Securities pursuant to Section 4(a)(2) under the Securities Act, with the terms of such offering (the “Offering”)
to be subject to market conditions and negotiations between the Company, the Placement Agent and the prospective Investors. The Placement
Agent will act on a reasonable best efforts basis and the Company agrees and acknowledges that there is no guarantee of the successful
placement of the Securities, or any portion thereof, in the prospective Offering. Under no circumstances will the Placement Agent or
any of its “Affiliates” (as defined below) be obligated to underwrite or purchase any of the Securities for its own account
or otherwise provide any financing. The Placement Agent shall act solely as the Company’s agent and not as principal. The Placement
Agent shall have no authority to bind the Company with respect to any prospective offer to purchase Securities and the Company shall
have the sole right to accept offers to purchase Securities and may reject any such offer, in whole or in part. Subject to the terms
and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall be made at one or more closings (each
a “Closing” and the date on which each Closing occurs, a “Closing Date”). As compensation for services
rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees and expenses set forth below:

 

	 	(i)	A
    cash fee equal to 8% of the gross proceeds received by the Company from the sale of the Securities at the Closing of the Offering
    to Investors.
	 	 	 
	 	(ii)	A
    cash fee equal to 8% of the gross proceeds received by the Company from any exercise of the Class C Warrants

 

    	 

     

    

 

(b)
(i) The Company hereby agrees to issue to the Placement Agent (and/or its designees)on the Closing Date, upon payment of $100.00 by the
Placement Agent on the Closing Date, warrants (“Placement Agent’s Warrants”) to purchase that number of shares
of Common Stock equal to 8% of the aggregate number of Conversion Shares placed in the Offering. The Placement Agent’s Warrant
agreement shall be exercisable, in whole or in part, commencing on the final Closing Date and shall be exercisable for a period of five
years. The Placement Agent’s Warrant shall be exercisable on a cashless basis. The Exercise price of the warrant shall be the same
as the Conversion Price of the Investor’s Note. The PlacementAgent’s Warrant Agreement and the shares of Common Stock issuable
upon exercise thereof (the “PA Warrant Shares”) are hereinafter referred to together as the “Placement Agent’s
Securities.”

 

	 	(ii)	The
    Company hereby agrees to issue to the Placement Agent (and/or its designees) , upon payment of $100 by the Placement Agent, warrants
    (“Placement Agent’s Warrants”) to purchase that number of shares of Common Stock equal to 8% of the aggregate
    number of Warrant Shares that are exercised. The Placement Agent’s Warrant agreement shall be exercisable, for a period of
    five years. The Placement Agent’s Warrant shall be exercisable on a cashless basis . The Exercise price of the Placement Agent
    Warrants shall be the same as the Exercise price of the Investor’s Warrants. The Placement Agent’s Warrant Agreement
    and the shares ofCommon Stock issuable upon exercise thereof (the “PA Warrant Shares”) are hereinafter referred
    to together as the “Placement Agent’s Securities.”

 

(iii)
The term of the Placement Agent’s exclusive engagement will be until the completion of the Offering (the “Exclusive Term”);
provided, however, that a party hereto may terminate the engagement with respect to itself at any time upon fifteen (15)
days written notice to the other parties (provided that no such notice may be given until January 31, 2022 except in the case of termination
for cause). Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification and
contribution contained herein and the Company’s obligations contained in the indemnification provisions will survive any expiration
or termination of this Agreement, and the Company’s obligation to pay fees actually earned and payable and to reimburse expenses
actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rules, will survive
any expirationor termination of this Agreement. Nothing in this Agreement shall be construed to limit the ability of the Placement Agent
or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any other business
relationship with Persons (as defined herein) other than the Company. As used herein (i) “Persons” means an individual
or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock
company, government (oran agency or subdivision thereof) or other entity of any kind and (ii) “Affiliate” means any
Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

Section
2. Representations and Warranties. The Company represents and warrants to the Placement Agent, as of the date hereof and as of the
Closing Date, all of the representations, warranties and agreements of the Company that were made by the Company to the Investor (as
defined in the Purchase Agreement) in the Purchase Agreement are true and correct with the same force and effect as of the date hereof
and as of the Closing Date as if made on the date hereof and each Closing Date, and that such representations and warranties are hereby
incorporated by reference herein. The Company agrees to all of the agreements and covenants with respect to the Company in the Purchase
Agreement with respect to the Placement Agent and that such agreements and covenants set forth are incorporated by reference herein.
In addition to the foregoing, the Company represents and warrants to the Placement Agent that:

 

(a)
(i) the Company has full right, power and authority to enter into this Agreement, to issue the Placement Agent’s Warrants and to
perform all of its obligations hereunder and consummate the transactions contemplated hereby and thereby; (ii) this Agreement and the
Placement Agent’s Warrant each has been duly authorized and executed and constitutes a legal, valid and binding agreement of such
party enforceable in accordance with its terms; (iii) the execution and delivery of this Agreement and the Placement Agent’s Warrants
and the consummation of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Warrants
and the issuance and reservation for issuance of the PA Warrant Shares issuable upon exercise thereof) have been duly authorized by the
Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholdersis
required; (iv) the execution and delivery of this Agreement and the Placement Agent’s Warrants and the consummation of the transactions
contemplated hereby and thereby does not conflict with or result in a breachof (x) the Company’s articles of incorporation or bylaws
or other charter documents, (y) any agreement to which the Company is a party or by which any of its property or assets is bound or (z)
any of the other itemsdescribed in Sections 3.2 and 3.3 of the Purchase Agreement.

 

    	 

     

    

 

(b)
All disclosure provided by the Company to the Placement Agent regarding the Company, its business and the transactions contemplated hereby,
taken together with all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and
Exchange Commission (the “Commission”) pursuant to the reporting requirements of the Exchange Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents (other
than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein as the “SEC Filings”),
is true and correct in all material aspects and does not contain any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.
To the best of the Company’s knowledge and belief, other than the current capital raising (of which this Agreement forms part),
no event or circumstance has occurred or information exists with respect to the Company or its business, properties, prospects, operations
or financial conditions, which, under the applicable laws, rules or regulations of the Commission, requires public disclosure or announcement
by the Company but which has not been so publicly announced or disclosed.

 

(c)
The Company has not taken and will not take any action, directly or indirectly, so as to cause the Offering to fail to be entitled to
rely upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act. In effecting the Offering, the Company agrees
to comply in all material respects with applicable provisions of the Securities Act and any regulations thereunder and any applicable
laws, rules, regulations and requirements (including, without limitation, all U.S. state law and all national, provincial, city or other
legal requirements).

 

(d)
Issuance of Placement Agent’s Warrant and PA Warrant Shares. The PA Warrant Shares are, or at the consummation of the Offering
will be, duly authorized and reserved for issuance and, upon exercise of the Placement Agent’s Warrants in accordance with its
respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances with
respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company and
will not impose personal liability upon the holder thereof.

 

Section
3. Delivery and Payment. Each Closing shall occur at the offices of Sullivan & Worcester, LLP, 405 1633 Broadway, 32nd
Floor, New York, New York 10019 (or at such other place as shall be agreed upon by the Placement Agent and the Company) (“Placement
Agent Counsel”). Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities
sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall
be registered in such name or names and shall be in such denominations, as the Placement Agent may request at least one (1) Business
Day (as defined in the Purchase Agreement) before the time of purchase.

 

Deliveries
of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent Counsel. All
actions taken at a Closing shall be deemed to have occurred simultaneously.

 

    	 

     

    

 

Section
4. Covenants and Agreements of the Company. The Company further covenants and agrees with the Placement Agent as follows:

 

(a)
Blue Sky Compliance. The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities
for sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably
request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose,
provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in
any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not
be required to produce any new disclosure document other than the Transaction Documents. The Company will, from time to time, prepare
and file such statements, reports and other documents as are or may be required to continue such qualifications in effect for so long
a period as the Placement Agent may reasonably request for distribution of the Securities. The Company will advise the Placement Agent
promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Securities for offering, sale
or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of
any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof
at the earliest possible moment.

 

(b)
Amendments and Supplements to the Transaction Documents and Other Matters. The Company will comply with the Securities Act and
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Commission
thereunder, so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and the Transaction
Documents. If, prior to the termination of the Offering, any event shall occur as a result of which, in the judgment of the Company or
in the opinion of the Placement Agent or Placement Agent Counsel, it becomes necessary to amend or supplement the Transaction Documents
in order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading,
or if it is necessary at any time to amend or supplement the Transaction Documents, the Company will promptly prepare and furnish at
its own expense to the Placement Agent and to dealers, an appropriate amendment or supplement to the Transaction Documents that is necessary
in order to make the statements therein as so amended or supplemented, in the light of the circumstances under which they were made,
as the case may be, not misleading, or so that the Transaction Documents, as so amended or supplemented, will comply with applicable
laws related to the Offering. Before amending or supplementing Transaction Documents in connection with the Offering, the Company will
furnish the Placement Agent with a copy of such proposed amendment or supplement and will not disseminate any such amendment or supplement
to which the Placement Agent reasonably objects. Notwithstanding any provision of this Section 4(b), the Company and its counsel shall
be afforded a reasonable opportunity to demonstrate why such amendment or supplement may not be necessary or advisable.

 

(c)
Copies of any Amendments and Supplements to the Transaction Documents. The Company will furnish the Placement Agent, without charge,
during the period beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of the
Transaction Documents and any amendments and supplements thereto as the Placement Agent may reasonably request.

 

(d)
Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock a sufficient number
of shares of Common Stock for issuance pursuant to the full exercise of the Placement Agent’s Warrant.

 

(e)
Transfer Agent. The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.

 

(f)
Registration of Securities; Exchange Approval. The Common Stock is registered under the Exchange Act and, as of the Closing Date,
the Conversion Shares, the Warrant Shares and PA Warrant Shares shall be, if and as applicable, either eligible for quotation on the
OTC markets or listed and admitted and authorized for trading on the Nasdaq Stock market or other applicable U.S. national exchange (the
“Trading Market”) (subject to any restrictions or conditions that may be imposed by the Trading Market or other applicable
U.S. national exchange) and satisfactory evidence of such action shall have been provided to the Placement Agent. For a period of three
(3) years, the Company shall take no action designed to, or likely to have the effect of terminating the registration of the Common Stock
under the Exchange Act or, if appliable, delisting or suspending from trading or quotation, as applicable, the Common Stock from the
Trading Market or other applicable U.S. national exchange and the Company has not received any information suggesting that the Commission
or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration, quotation, or listing.

 

(g)
Additional Documents. The Company will enter into any subscription, purchase or other customary agreements as the Placement
Agent or the Investors reasonably deem necessary or appropriate to consummate the Offering, all of which will be in form and substance
reasonably acceptable to the Placement Agent and the Investors. The Company agrees that the Placement Agent may rely upon, and

 

    	 

     

    

 

each is a third-party
beneficiary of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other agreement
with Investors in the Offering.

 

(h)
No Manipulation of Price. The Company will not take, directly or indirectly, any action designed to cause or result in,
or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities
of the Company.

 

(i)
Acknowledgment. The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit
and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement
Agent’s prior written consent.

 

Section
5. Conditions of the Obligations of the Placement Agent. The obligations of the Placement Agent hereunder shall be subject to the
accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date
hereof and as of each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations
hereunder on and as of such dates, and to each of the following additional conditions:

 

(a)
No Untrue Statements. The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date
that the SEC Filings contains an untrue statement of a fact which, in the opinion of Placement Agent’s Counsel, is material or
omits to state any fact which, in the opinion of such counsel, is material and is required to be stated therein or is necessary to make
the statements therein not misleading.

 

(b)
Compliance with Regulatory Requirements. No order having the effect of ceasing or suspending the distribution of the Securities
or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock
exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated
by any securities commission, securities regulatory authority or stock exchange.

 

(c)
Corporate Proceedings. All corporate proceedings and other legal matters in connection with this Agreement, the Transaction Documents,
and the registration or exemption therefrom, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably
satisfactory to the Placement Agent Counsel, and such counsel shall have been furnished with such papers and information as it may reasonably
have requested to enable such counsel to pass upon the matters referred to in this Section 5.

 

(d)
No Material Adverse Change. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date (if there
shall be more than one Closing Date then prior to each Closing Date), in the Placement Agent’s sole judgment after consultation
with the Company, there shall not have occurred any Material Adverse Effect (as defined in the Purchase Agreement).

 

(e)
Secretary’s Certificate. At the Closing Date (if there shall be more than one Closing Date then at each Closing Date), the
Placement Agent shall have received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date certifying:
(i) that each of the Company’s charter and bylaws is true and complete, has not been modified and is in full force and effect;
(ii) that the resolutions of the Company’s Board of Directors relating to the Offering are in full force and effect and have not
been modified; (iii) as to the accuracy and completeness of all correspondence between the Company or its counsel and the Commission;
and (iv) as to the incumbency of the officers of the Company. The documents referred to in such certificate shall be attached to such
certificate.

 

(f)
Officer’s Certificate. The Placement Agent shall have received on the Closing Date (if there shall be more than one Closing
Date then on each Closing Date) a certificate of the Company, dated as of such Closing Date, signed by the Chief Executive Officer and
Chief Financial Officer of the Company, to the effect that, and the Placement Agent shall be satisfied that, the signers of such certificate
have reviewed this Agreement and the Transaction Documents and to the further effect that:

 

    	 

     

    

 

(g)
Stock Exchange Listing. The Common Stock shall be registered under the Exchange Act and shall be if and as applicable, either
admitted for quotation or listed on the Trading Market, and the Company shall not have taken any action designed to terminate, or likely
to have the effect of terminating, the registration of the Common Stock under the Exchange Act or termination of quotation, delisting
or suspending from trading the Common Stock from the Trading Market, nor shall the Company have received any information suggesting that
the Commission or the Trading Market is contemplating terminating such registration, quotation, or listing.

 

(h)
Placement Agent’s Warrant Agreements. On or before the Closing Date (if there shall be more than one Closing Date then on
or before each Closing Date), the Placement Agent shall have received executed copies of the Placement Agent’s Warrant Agreements,
provided the Company has received the Placement Agent’s designees for such Warrant Agreements at least two (2) business days prior
to Closing Date.

 

(i)
Additional Documents. On or before each Closing Date (if there shall be more than one Closing Date then on or before each Closing
Date), the Placement Agent and counsel for the Placement Agent shall have received such information and documents as they may reasonably
require for the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated herein, or in order to
evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein
contained.

 

(j)
Opinion of Counsel. On or before each Closing Date (if there shall be more than one Closing Date then on or before each Closing
Date), an opinion of Sullivan & Worcester, counsel to the Company, in form and substance satisfactory to the Placement Agent.

 

If
any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by
the Placement Agent by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability
on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution)
and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.

 

Section
6. Payment of Expenses. The Company agrees to pay all actual and reasonable costs, fees and expenses incurred by the Company in connection
with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation:
(i) all expenses incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs);
(ii) all fees and expenses of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp
taxes in connection with the issuance and sale of the Securities; (iv) all fees and expenses of the Company’s counsel, independent
public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing,
filing, shipping and distribution of the Transaction Documents, and all amendments and supplements thereto, and this Agreement; (vi)
all filing fees, reasonable attorneys’ fees and expenses incurred bythe Company or the Placement Agent in connection with qualifying
or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer and sale
under the state securities or blue sky laws or the securities laws of any other country; (vii) the fees and expenses associated with
including the Securities on the Trading Market; and (viii) the fees and expenses of the Placement Agent’s due diligence; and legal
counsel; provided, however, the maximum amount of this reimbursement for clause (viii) shall in an aggregate amount not
to exceed $60,000 if the gross amount raised is $6 Million and in an aggregate amount not to exceed $100,000 if the gross amount raised
is over $6 Million; unless, with respect to one of more of clauses (i) – (viii) the Company otherwise agrees in writing, and if
the Offering is terminated without a Closing then such amount shall not exceed

$35,000.

 

    	 

     

    

 

Section
7. Indemnification and Contribution.

 

(a)
The Company agrees to indemnify and hold harmless the Placement Agent, its Affiliates and each person controlling the Placement Agent
(within the meaning of Section 15 of the Securities Act), and the directors, officers, agents and employees of the Placement Agent, its
Affiliates and each such controlling person (the Placement Agent, and each such entity or person, an “Indemnified Person”)
from and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the “Liabilities”),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of one counsel for
all Indemnified Persons, except as otherwise expressly provided herein) (collectively, the “Expenses”) as they are
incurred by an Indemnified Person in investigating, preparing, pursuing or defending any Actions, whether or not any Indemnified Person
is a party thereto, (i) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material
fact contained in any Transaction Document or by any omission or alleged omission to state therein a material fact necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading (other than untrue statements or alleged
untrue statements in, or omissions or alleged omissions from, information relating to an Indemnified Person furnished in writing by or
on behalf of such Indemnified Person expressly for use in the Transaction Documents) or (ii) otherwise arising out of or in connection
with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated
thereby or any Indemnified Person’s actions or inactions in connection with any such advice, services or transactions; provided,
however, that, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that are finally
judicially determined to have resulted solely from such Indemnified Person’s (x) gross negligence or willful misconduct in connection
with any ofthe advice, actions, inactions or services referred to above or (y) use of any offering materials or information concerning
the Company in connection with the offer or sale of the Securities in the Offering which were not authorized for such use by the Company
and which use constitutes gross negligence or willful misconduct. The Company also agrees to reimburse each Indemnified Person for all
Expenses as they are incurred in connection with enforcing such Indemnified Person’s rights under this Agreement.

 

(b)
Upon receipt by an Indemnified Person of actual notice of an Action against such Indemnified Person with respect to which indemnity may
be sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; provided that failure by any Indemnified
Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of this indemnity
or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The Company shall,
if requested by the Placement Agent, assume the defense of any such Action including the employment of counsel reasonably satisfactory
to the Placement Agent, which counsel may also be counsel to the Company. Any Indemnified Person shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named parties
to any such Action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person shall
have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; provided that the Company
shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all Indemnified
Persons in connection with any Action or related Actions (as defined herein), in addition to any local counsel. The Company shall not
be liable for any settlement of any Action effected without its written consent (which shall not be unreasonably withheld). In addition,
the Company shall not, without the prior written consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise
or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened Action in respect of which indemnification
or contribution may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise,
consent or termination includes an unconditional release of each Indemnified Person from all Liabilities arising out of such Action for
which indemnification or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is
due and payable. “Action” means any action, suit, inquiry, notice of violation, proceeding or investigation affecting
the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign).

 

    	 

     

    

 

(c)
In the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other
hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate,
as well as any other relevant equitable considerations; provided that in no event shall the Company contribute less than the amount necessary
to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount of
fees actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to the
Company, on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed
to be in the same proportion as (a) the total value paid or contemplated to be paid to or received or contemplated to be received by
the Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated,
bears to (b) the fees paid to the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, as amended, shall be entitled to contribution from a party who was not guilty
of fraudulent misrepresentation.

 

(d)
The Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person’s actions or inactions in connection with any such advice, services
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted
solely from such Indemnified Person’s gross negligence or willful misconduct in connection with any such advice, actions, inactions
or services.

 

(e)
The reimbursement, indemnity and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person’s services
under or in connection with, this Agreement.

 

Section
8. Representations and Indemnities to Survive Delivery. The respective indemnities, agreements, representations, warranties and other
statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant
to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent,
the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery
of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to the Placement Agent, or to the
Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution
and reimbursement agreements contained in this Agreement.

 

Section
9. Notices. All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to the
parties hereto as follows:

 

If
to the Placement Agent to:

 

Univest
Securities LLC

Investment
Banking

375
Park Avenue, 15th Fl.

New
York, New York 10152

Attention:
Bradley Richmond

Email:
brichmond@univest.us

 

With
a copy to:

 

Sullivan
& Worcester, LLP

1633
Broadway

New
York, New York 10019

Attention:
David Danovitch, Esq.

Email:
Ddanovitch@sullivanlaw.com

 

    	 

     

    

 

If
to the Company:

 

555
Heritage Dr.

Jupiter,
FL 33458

Attention:
David Barthel, CEO

Email:
dbarthel@marizyme.com

 

Any
party hereto may change the address for receipt of communications by giving written notice to the others.

 

Section
10. Right of First Refusal and Participation Rights. Subject to consummation of the Offering, if, from the date hereof until the
12-month anniversary following the consummation of the Offering (the “ROFR Period”), the Company or any of its subsidiaries
decides to raise funds by means of a public offering (including at-the-market facility) or a private placement or any other capital raising
financing of equity or equity-linked securities using an underwriter or placement agent, the Placement Agent (or any affiliate designated
by the Placement Agent) shall have the right to act as an underwriter or sole placement agent for such financing. If the Placement Agent
or one of its affiliates decides to accept any such engagement, the agreement governing such engagement will contain, among other things,
provisions for customary fees for transactions of similar size and nature and the provisions of this Agreement, including indemnification,
which are appropriate to such a transaction.

 

Section
11. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees,
officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative,
and no other person will have any right or obligation hereunder.

 

Section
12. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph or provision hereof. If any Section, paragraph or provision of
this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and enforceable.

 

Section
13. Governing Law Provisions. This Agreement shall be deemed to have been made and delivered in New York City and both this Agreement
and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects
by the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Each of the Placement Agent
and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement and/or the transactions
contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States District Court
for the Southern District of New York, (ii) waives any objection which it may have or hereafter to the venue of any such suit, action
or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and the United States
District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Placement Agent and the Company
further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding in
the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York and agrees
that service of process upon the Company mailed by certified mail to the Company’s address shall be deemed in every respect effective
service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Placement Agent mailed by
certified mail to the Placement Agent’s address shall be deemed in every respect effective service process upon the Placement Agent,
in any such suit, action or proceeding. Notwithstanding any provision of this Agreement to the contrary, the Company agrees that neither
the Placement Agent nor its Affiliates, and the respective officers, directors, employees, agents and representatives of the Placement
Agent, its Affiliates and each other person, if any, controlling the Placement Agent or any of its Affiliates, shall have any liability
(whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction
described herein except for any such liability for losses, claims, damages or liabilities incurred by us that are finally judicially
determined to have resulted from the bad faith or gross negligence of such individuals or entities. If either party shall commence an
action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed
by the other party for its reasonable attorney’s fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.

 

    	 

     

    

 

Section
14. General Provisions.

 

(a)
This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or
more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein
(express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein
are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.

 

(b)
The Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent has acted at arms’ length,
are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those
duties and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the Company.
The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an
alleged breach of fiduciary duty in connection with the offering of the Securities.

 

Section
15. Fee Tail. The Placement Agent shall be entitled to the cash fees and Placement Agent’s Warrants calculated in the manner
described in Section 1 hereto with respect to any private or public offering or other financing or capital raising transaction of any
kind consummated within 12 months period of the termination or expiration of this Agreement with an investor whom the Placement Agent
has, directly or indirectly, introduced to the Company during the term of this Agreement.

 

[The
remainder of this page has been intentionally left blank.]

 

    	 

     

    

 

If
the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.

 

Accepted
and Agreed to as of the date first written above:

 

	UNIVEST
    SECURITIES LLC	 
	 	 	 	 	 
	By:	/s/
    Yi (Edric) Guo	 	12/10/2021	 
	Name:	Yi
    (Edric) Guo	 	 	 
	Title:	Chief Operating Officer	 
	 	 	 	 	 
	MARIZYME
    INC.	 	 	 
	 	 	 	 	 
	By:	/s/
    David Barthel	 	12/10/2021	 
	Name:	David
    Barthel	 	 	 
	Title:	CEOExhibit
10.8 

 

MARIZYME,
INC.

 

CONSULTING
AGREEMENT

 

THIS
CONSULTING AGREEMENT (this “Agreement”) is entered into effective as of December 21, 2021 (“Effective
Date”) by and among Marizyme, Inc. a Nevada corporation (the “Company”), AAT Services Inc., a corporation
incorporated pursuant to the laws of British Columbia, Canada (“AAT”) and George Kovalyov, an individual (“Principal”
and together with AAT, the “Consultant”). The Company together with the Consultant, the “Parties,”
and each individually, a “Party”.

 

WHEREAS,
Consultant has certain expertise and know-how and the Company desires to engage the Consultant to assist in the growth and development
of the Company’s business, and the Consultant has agreed to provide such consulting services on and subject to the terms and conditions
of this Agreement.

 

NOW,
THEREFORE, in consideration of the aforementioned recitals incorporated by reference and the mutual covenants, terms and conditions set
forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties
agree as follows:

 

AGREEMENT

 

1.
Services. The Company hereby engages Consultant
as an independent contractor to provide certain services to the Company in relation to Consultant’s expertise and as set forth
on Exhibit A (the “Services”) during the Term (as defined below) of this Agreement and Consultant hereby accepts
such engagement and agrees to provide the Services in accordance with the terms of this Agreement.

 

2.
Compensation.

 

2.1
Compensation. As compensation for the Services,
the Company shall pay Consultant in accordance with, and subject to the conditions set forth therein, the Compensation set forth in Exhibit
B (the “Compensation”). Consultant shall receive and acknowledges to receive an IRS Form 1099 from the Company
for the total Compensation and Expenses (as defined below) for which Consultant shall be solely responsible for all federal, state and
local taxes.

 

3.
Expenses. Following the prior written
approval by the Company in each case, the Company shall pay for Consultant’s invoiced expenses for necessary travels and other
necessary costs that are in furtherance of the Services (the “Expenses” or an “Expense”). To obtain
a payment in each case of an Expense, Consultant shall promptly submit to the Company a receipt and documentation describing the Expense
and the amount paid.

 

4.
Independent Contractor Relationship. Consultant’s
relationship with the Company is that of an independent contractor, and nothing in this Agreement is intended to, or should be construed
to, create any association, partnership, agency, joint venture or employment relationship between the Company and Consultant or any of
the Consultant’s employees or agents. The Consultant acknowledges that the Consultant has no authority (and shall not hold itself
out as having authority) to bind the Company to any agreement.

 

    	 

     

    

 

4.1
Method of Providing Services. Consultant shall
be solely responsible for determining the method, details and means of performing the Services, subject to compliance with the terms
of this Agreement. Consultant shall furnish its own materials, equipment, supplies, expenses and other resources necessary to perform
the Services. The Company shall provide Consultant with access to its materials, information and systems to the extent necessary for
the performance of the Services and subject to the confidentiality obligations herein.

 

4.2
No Benefits. Consultant and any of Consultant’s
employees or agents will not be entitled to any of the benefits that Company may make available to its employees or other agents, including,
but not limited to, vacation, medical, dental, group health insurance, life insurance, workers’ compensation, death and/or disability
insurance, profit-sharing or retirement benefits, or any other fringe benefits or benefits plans offered by the Company to its employees.

 

4.3
No Withholdings; Taxes; Reclassification. Because
Consultant is an independent contractor, the Company will not withhold or make payments for social security, unemployment insurance,
disability insurance contributions, payroll taxes, income taxes, or other federal, state or local taxes, or workers’ compensation
insurance on behalf of Consultant. Consultant is solely responsible for, and will file, on a timely basis, all tax returns and payments
required to be filed with, or made to, any federal, state or local tax authority with respect to the performance of Services and receipt
of fees under this Agreement. Consultant shall indemnify the Company against all such taxes or contributions, including penalties and
interest. Consultant is solely responsible for, and must maintain adequate records in relation to any such documentation necessary for
any federal, state or local laws or taxes in relation to performing the Services under this Agreement. If, notwithstanding the foregoing,
Consultant is reclassified as an employee of Company, or any affiliate of Company, by the U.S. Internal Revenue Service, the U.S. Department
of Labor, or any other federal or state or foreign agency as the result of any administrative or judicial proceeding, Consultant agrees
that Consultant will not, as the result of such reclassification, be entitled to or eligible for, on either a prospective or retrospective
basis, any Consultant benefits under any plans or programs established or maintained by Company.

 

5.
Term and Termination.

 

5.1
Term. The term of this Agreement is for twelve
(12) months from the Effective Date set forth above (the “Initial Term”), unless earlier terminated as provided in
this Agreement. If Consultant is terminated at any time during the Initial Term for a reason other than Cause (as defined below), the
Company shall pay to Consultant $21,429.00 plus any Compensation due and payable to, earned or accrued by, Consultant and not yet paid
by the Company. This Agreement automatically renews for subsequent six (6) month extensions (“Extended Term,” and
together with the Initial Term, the “Term”) following the end of the Initial Term or each Extended Term except if
terminated as set forth in Section 5.2 below.

 

    	2

     

    

 

“Cause”
shall mean (i) the Consultants repeated willful misconduct or gross negligence in the performance of the Services to the Company or its
subsidiaries; (ii) the Consultant’s repeated failure to perform the Services for the Company or its subsidiaries; (iii) the Consultant’s
conviction of, or pleading of guilty or nolo contendere to, a felony or any crime involving moral turpitude; (iv) the Consultant’s
performance of any material act of theft, embezzlement, fraud, malfeasance, dishonesty or misappropriation of the Company’s or
its subsidiaries’ property; (v) the Consultant’s use of illegal drugs or the Consultant’s abuse of alcohol that materially
impairs the Consultant’s ability to perform the Services for the Company or its subsidiaries; (vi) the death of Consultant or a
disability of Consultant such that Consultant is unable to perform the Services in whole or in part due to any disability or illness,
whether physical, emotional or mental; or (vii) if Consultant materially breaches this Agreement and Consultant fails to cure such breach
within thirty (30) days after receipt of written notice specifying such material breach in reasonable detail.

 

5.2
Termination. Either Party may terminate this
Agreement upon 30-days written notice to the other Party. Notwithstanding the foregoing, any Compensation due and payable to, earned
or accrued by, Consultant prior to the termination under this Section 5, shall be paid to Consultant within 10 days of termination.

 

6.
Confidentiality, Non-Compete, and Other Covenants.

 

6.1
Preservation of Confidential Information. Consultant
agrees at all times:

 

(a)
Not to disclose to any third party any Confidential
Information learned by Consultant at any time or any Confidential Information developed by Consultant pursuant to this Agreement; except
such information which is now public or hereafter becomes published or otherwise generally available to the public other than through
breach of this Agreement;

 

(b)
That Consultant will only disclose
Confidential Information to employees, agents or Subcontractors of Consultant who have a need to know such information in order to carry
out Consultant’s responsibilities hereunder, and only then to those who have been advised that such information is confidential
and proprietary and then only to those who have agreed to accept the same obligation of confidentiality and non-use as Consultant;

 

(c)
Even after any Confidential Information obtained by
Consultant or any Confidential Information developed by Consultant pursuant to this Agreement becomes generally available to the public,
not to disclose the fact that such information was furnished to Consultant by Company, originated with Company, an affiliate or related
company, or was developed by Consultant pursuant to this Agreement, unless that fact is also published; and

 

(d)
Not to put to commercial use
or use in any way except for the benefit of Company any Confidential Information disclosed to Consultant or any Confidential Information
developed by Consultant pursuant to this Agreement.

 

(e)
As used herein, “Confidential
Information” includes any non-public information Consultant receives directly or indirectly from the Company or acquired or
developed in the course of his, her or its consultancy and any other non-public information received or developed by, or disclosed to,
Consultant during the course of or arising out of his, her or its previous employment with the Company, including by way of example only,
trade secrets (including organizational charts, employee information such as credentials, skill sets and background information), ideas,
inventions, methods, designs, formulas, systems, improvements, prices, discounts, business affairs, products, product specifications,
manufacturing processes, data and know-how and technical information of any kind whatsoever, unless such information has been publicly
disclosed by authorized officials of the Company. In the event information which is non-public becomes public due to disclosure by Consultant
which is not authorized by the Company, such information shall be deemed non-public for purposes of this Agreement.

 

    	3

     

    

 

(f)
For the avoidance of doubt,
the Consultant may disclose the Confidential Information to the extent required by law or order of a court or governmental agency. However,
in such case, Consultant must give the Company prompt notice and consult with the Company about whether to obtain a protective order
or otherwise protect the confidentiality of the Confidential Information, all as directed by and at the Company’s expense.

 

(g)
Great loss and immediate and
irreparable injury may be suffered by the Company if the Consultant should breach or violate any of the covenants and agreements set
forth in this clause. The parties agree that such covenants and agreements are reasonably necessary to protect and preserve the Company’s
interests.

 

6.2
Non-Solicitation. As a condition to this Agreement,
Consultant agrees that during the Term of this Agreement and for a period of one (1) year following the termination or expiration of
this Agreement, Consultant shall not make any solicitation to employ the Company or its subsidiaries’ personnel without written
consent of the Company to be given or withheld in the Company’s sole discretion. For the purposes of this Section 6.2, a general
advertisement or notice of a job listing or opening or other similar general publication of a job search or availability to fill employment
positions, including on the internet, shall not be construed as a solicitation or inducement, and the hiring of any such employees or
independent contractor who freely responds thereto shall not be a breach of this Section 6.2.

 

6.3
Access. Promptly upon request, Consultant shall
provide all information and documents relating to the Services, including, but not limited to, all licenses, consents, contracts, user
names, registrations, passwords, codes and other information in relation to the Services and to access and fully control any software,
websites, or other intellectual property established for the Company.

 

7.
Intellectual Property.

 

7.1
Intellectual Property Rights. The Company is
and will be the sole and exclusive owner of all right, title, and interest throughout the world in and to all the results and proceeds
of the Services performed under this Agreement (the “Deliverables”), and as a material condition to which Consultant
agrees in exchange for the opportunity to provide the Services, Consultant expressly acknowledges and agrees that all other writings,
reports, documents, improvements, discoveries, technologies, inventions, processes, techniques, methods, ideas, concepts, research, designs,
plans, proposals, and materials, and all other work product of any nature whatsoever, that is created, prepared, produced, authored,
edited, modified, conceived, or reduced to practice in the course of performing the Services (collectively, and including the Deliverables,
“Work Product”), whether of a technical nature or not, made or developed by Consultant alone or in conjunction with
any other person or entity while providing the Services or developed by the Consultant during the course of or arising out of his previous
employment with the Company, which relate to or affect the business of Company, including all patents, copyrights, trademarks (together
with goodwill symbolized thereby), trade-secrets, know-how, and other confidential or proprietary information, and other intellectual
property rights (collectively “Intellectual Property”) therein, shall be the sole and exclusive property of Company.
Consultant expressly agrees to disclose and reveal to Company all Work Product and Intellectual Property, and all information regarding
Work Product and Intellectual Property, concurrent with the discovery or development of such Work Product and Intellectual Property.
Consultant hereby agrees that the Work Product is hereby deemed “work made for hire” as defined in 17 U.S.C., Section 101
for the Company and all copyrights therein automatically and immediately vest in the Company. If, for any reason, any Work Product does
not constitute “work made for hire,” Consultant hereby irrevocable assigns to Company all Consultant’s rights, title,
and interests throughout the world in and to any such Work Product or Intellectual Property, including the right to sue for past, present
and future infringement, misappropriation, or dilution thereof. Consultant agrees that he, she or it will not use or disclose any Work
Product or Intellectual Property owned by Company to benefit a competitor, customer, individual, or other entity without the express
written permission of an executive officer of the Company. The Consultant irrevocably appoints the Company as his, her or its attorney
and, in his, her or its name and on his, her or its behalf, to execute and do any instrument or thing and generally to use his, her or
its name for the purpose of giving to the Company or its nominee the full benefit of the provisions of this Section 7.1.

 

    	4

     

    

 

7.2
Copyrights. To the extent any copyrights are
assigned under this Section 7.2, Consultant hereby irrevocably waives in favor of the Company, to the extent permitted by applicable
law, any and all claims Consultant may now or hereafter have in any jurisdiction to all rights of paternity or attribution, integrity,
disclosure, and withdrawal and any other rights that may be known as “moral rights” in relation to all Work Product to which
the assigned copyrights apply.

 

7.3
Further Assurances. Upon the reasonable request
of the Company, during and after the Term, Consultant shall promptly take such further actions, including execution and delivery of all
appropriate instruments of conveyance, and provide such further cooperation, as may be reasonably necessary to assist the Company to
apply for, prosecute, register, maintain, perfect, record, or enforce its rights in any Work Product and all Intellectual Property. In
the event the Company is unable, after reasonable effort, to obtain Consultant’s signature on any such documents, Consultant hereby
irrevocably designates and appoints the Company as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s
behalf solely to execute and file any such application or other document and do all other lawfully permitted acts to further the prosecution
and issuance of patents, copyrights, or other intellectual property protection related to the Work Product with the same legal force
and effect as if Consultant had executed them. Consultant agrees that this power of attorney is coupled with an interest.

 

7.4
Company Materials. As between Consultant and
the Company, the Company is, and will remain, the sole and exclusive owner of all right, title, and interest in and to any documents,
specifications, data, know-how, methodologies, software, and other materials provided to Consultant by the Company (“Company
Materials”), including all intellectual property rights therein. Consultant has no right or license to reproduce or use any
Company Materials except solely during the Term to the extent necessary to perform Consultant’s obligations under this Agreement.
All other rights in and to the Company Materials are expressly reserved by the Company. Consultant has no right or license to use the
Company’s trademarks, service marks, trade names, logos, symbols, or brand names.

 

    	5

     

    

 

7.5
Engagements with Employees and Third Parties.
Prior to Consultant disclosing any Confidential Information to any employee or third party, Consultant shall ensure that such employee
or third party is bound by obligations of confidentiality (substantially similar in content to this Agreement) for the benefit of Company.

 

8.
Surrender of Material upon Termination of Agreement.
Upon termination of this Agreement, Consultant shall return immediately to the Company all Intellectual Property (including all books,
records, notes, data and information relating to Company or its business and all other Company property), and will so certify in writing
that he, she or it has done so.

 

9.
Representations and Warranties. Consultant
hereby represents and warrants the following:

 

9.1
Authorization. Consultant has the right to enter
into and grant the rights granted in this Agreement and the Invention Assignment Agreement and to perform fully all of the Consultant’s
obligations under this Agreement and the Invention Assignment Agreement.

 

9.2
No Conflict. Consultant is not bound by any duty
to or agreement or arrangement with any other person that would conflict with this Agreement.

 

9.3
Consents. Consultant shall not, in performing
the Services, use or disclose to Company any confidential information, trade secrets, images, names or any other property or intellectual
property rights of any third party, person or entity (“Person”) without such Person’s written consent the scope
of which conforms to the intended use of such property pursuant to this Agreement. Prior to the performance of the Services, Consultant
has and shall obtain all consents, licenses and usage rights for the use of any such property in the performance of Services and to the
full extent needed for this Agreement.

 

9.4
Compliance with Laws. Prior to the performance
of the Services, Consultant shall obtain all required consents, licenses, approvals and certifications from any government or regulatory
agency necessary for the performance of this Agreement, and Consultant shall comply with all applicable laws and regulations.

 

9.5
No Violations and Non-Infringement. This Agreement
and Consultant’s agreement to provide the Services to Company does not violate any contractual obligation of Consultant to any
third party or Person, and providing the Services to Company or using the Pre-Existing Materials will not violate or infringe the copyright,
patent, intellectual property or other proprietary right of any third party.

 

10.
Indemnification. The Parties agree to
defend, indemnify and hold the other Party, its affiliates, and their respective officers, directors, employees, and agents harmless
from and against any and all claims, demands, actions, liabilities, damages, losses and expenses, including attorneys’ fees and
costs of litigation, arising out of the performance or material breach of the indemnifying Party under this Agreement or the Invention
Assignment Agreement, including, without limitation, the indemnifying Party’s representations, warranties and covenants hereunder.

 

    	6

     

    

 

11.
Limitation on Liability. UNDER NO CIRCUMSTANCES
AND UNDER NO LEGAL THEORY (WHETHER IN TORT, CONTRACT, STATUTORY OR OTHERWISE) WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, SPECIAL,
INCIDENTAL, CONSEQUENTIAL, PUNITIVE, LOST PROFITS, EXEMPLARY OR OTHER DAMAGES OF SIMILAR CHARACTER, EVEN IF IT HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES, ARISING FROM SUCH PARTY’S PERFORMANCE OR NON-PERFORMANCE OF THIS AGREEMENT. THE TOTAL AGGREGATE, CUMULATIVE
LIABILITY TO CONSULTANT ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL NOT EXCEED THE TOTAL AMOUNT OF COMPENSATION PROVIDED IN SECTION
2.

 

12.
Miscellaneous.

 

12.1
Survival. The rights and obligations contained
in Sections 5, 6, 7, 8, 10, and 11 will survive the expiration or termination of this Agreement.

 

12.2
Consent to Injunction. Consultant acknowledges
that in the event of a material breach of this Agreement, including, without limitation, a breach of any of the terms of Sections 5,
6, 7, 8, 9, and 10, monetary damages alone would not adequately compensate Company for the harm suffered. As such, Company shall be entitled
to injunctive relief to enjoin any breach or threatened breach of this Agreement, in addition to any other available remedies. Consultant
shall be liable for all damages, sustained by Company as a result of Consultant’s breach or threatened breach of this Agreement.

 

12.3
Notices. All notices required or permitted
hereunder shall be in writing and deemed properly given when delivered in person to Principal or to a corporate officer of AAT and to
a corporate officer of the Company, as the case may be, or when deposited in the United States mail, postage prepaid and properly addressed
to the Party to be notified, if to Principal, to 34-11551 Kingfisher Dr, Richmond, British Columbia, Canada; if to AAT, to 34-11551 Kingfisher
Drive, Richmond, BC, Attn: George Kovalyov, President, and if to Company, to its Secretary, at the principal executive office, or to
any such other address as shall have last been given by the Party to be notified.

 

12.4
Assignments. This Agreement may be assigned
at any time by Company to any related corporation or a successor corporation. In the event of such an assignment, the assignee corporation
(“Assignee”) to which the Agreement is assigned shall automatically be substituted for the assignor Company for all
intents and purposes and to the same extent as if the Assignee were the Company that had originally executed this Agreement. The Consultant
may not assign or transfer all or any portion of the contract without the Company’s prior written consent, except that in the event
of the Principal’s death the compensation due and owing the Principal may be paid in accordance with any assignment of death benefits.
Any assignment in violation of the foregoing shall be deemed null and void. Subject to the foregoing limitations, this Agreement will
enure to the benefit of, be binding on, and be enforceable against each of the Parties hereto and their respective successors and assigns.

 

12.5
Waiver. The waiver by any Party of a default
or a breach of any provision of this Agreement by another Party shall not operate or be construed as a waiver of any subsequent default
or breach, including, but not limited to, the continued performance of any term without notice required shall not operate or be construed
as a waiver of a subsequent required notice of the same event.

 

    	7

     

    

 

12.6
Modifications. The provisions of this
Agreement may only be modified by an agreement in writing signed by the Party against whom enforcement is sought.

 

12.7
Attorneys’ Fees. The prevailing
Party in any action brought to enforce this Agreement may recover reasonable attorneys’ fees and costs including all costs and
fees incurred in the preparation, trial and appeal of an action brought to enforce this Agreement.

 

12.8
Choice of Law and Venue. This Agreement, together
with any and all modifications, extensions, exhibits, and amendments, and all matters arising directly or indirectly herefrom shall be
construed and governed by the laws of the State of Florida. The Parties hereby irrevocably consent and agree to submit to exclusive venue
in Palm Beach County, Florida in connection with any legal action, lawsuit, arbitration, mediation or other legal or quasi legal proceeding,
directly or indirectly arising out of or relating to this Agreement. The Parties expressly waive any challenges to exclusive venue or
personal jurisdiction in the State of Florida.

 

12.9
Severability. The parties agree that any provision
of this Agreement or its application which is held illegal, invalid or unenforceable shall be modified as necessary to render such provision
legal, valid and enforceable. If any provision of this Agreement or its application is held illegal, invalid or unenforceable and cannot
be modified to render such provision legal, valid and enforceable, such provision shall be interpreted as narrowly as possible and shall
be deemed stricken and severed from this Agreement, and all other parts, terms, provisions, and portions of this Agreement shall remain
unaffected and shall be given full force and effect.

 

12.10
Entire Agreement. This Agreement and any attachments
and exhibits constitutes the entire agreement between the parties relating to this subject matter and supersedes all prior or contemporaneous
oral or written agreements concerning such subject matter.

 

12.11
Counterparts. This Agreement may be executed
in one or more counterparts, each of which shall be deemed an original and all of which shall be taken together and deemed to be one
instrument. This Agreement may be executed and delivered by facsimile signature, PDF or any other electronic signature which complies
with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com).

 

[Signatures
on the next page.]

 

    	8

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the Effective Date.

 

	 	CONSULTANT
	 	 	 
	 	AAT
    Services Inc., 
	 	a
    British Columbia corporation
	 	 	 
	 	By:	 /s/
                                            George Kovalyov 

	 	 	George
    Kovalyov
	 	 	Director
	 	 	 
	 	PRINCIPAL
	 	 	 
	 	 /s/ George Kovalyov 
	 	George Kovalyov
	 	 	 
	 	COMPANY
	 	 	 
	 	MARIZYME,
    INC.,
	 	a
    Nevada corporation
	 	 	 
	 	By:
    	 /s/
    David Barthel 
	 	 	David
    Barthel
	 	 	CEO

 

[Signature
page to Consulting Agreement]

 

    	 

     

    

 

EXHIBIT
A

 

SERVICES

 

Services:

 

Consultant
shall render such services as Company may from time to time request, including, without limiting the generality of the foregoing, the
following:

 

	 	●	Proper
    filing of quarterly and annual reports.
	 	●	Budgeting,
    allocation of capital, and payroll processes.
	 	●	Assistance
    in the preparation of an S-1 document and other Nasdaq preparations.
	 	●	Assistance
    with Corporate Governance creations and procedures. 
	 	●	The
    creation of valuation reports for DuraGraft, Krillase, and MATLOC.
	 	●	Preparation
    of investment material for current and prospective shareholders.
	 	●	General
    business development; looking for potential partners and financing opportunities. 

 

    	 

     

    

 

EXHIBIT
B

 

COMPENSATION

 

Compensation:
The Compensation for Consultant’s Services pursuant to the Consulting Agreement between Consultant and the Company (the “Agreement”)
shall be the following:

 

	 	●	Cash
    Compensation: 

 

	 	○	The
    Company shall pay and the Consultant shall receive a fixed amount of Seven Thousand One Hundred Forty-Three Dollars ($7,143.00) (the
    “Base”) for each month that the Consultant provides services to the Company. For any month in which the Agreement
    is terminated, the Company shall pay, and the Consultant shall receive a pro-rated portion of the Base equal to the percentage of
    days in a 30 day month. 
	 	 	 
	 	○	The
    Company shall pay and the Consultant shall receive reimbursement for all Expenses incurred by Consultant under Section 3 of the Agreement
    (the “Reimbursements”).
	 	 	 
	 	○	The
    Company shall pay all outstanding Base and Reimbursements due and payable to, earn or accrued by, Consultant, to Consultant no later
    than the 10th day following the termination of the business relationship.

 

	 	●	Equity
    Compensation: The Company shall grant the Consultant the following equity Compensation as of the date of the Agreement, subject
    to the terms and conditions set forth below:

 

	 	○	Warrants:
    The Company shall grant, on the date hereof, Consultant cashless warrants to purchase 100,000 shares of common stock of the Company,
    with an exercise price of $1.26 (the “Warrants”). The Company shall provide Consultant with a Warrant Agreement,
    substantially in the form attached hereto as Exhibit C.
	 	 	 
	 	○	Options:
    The Company shall grant, on the date hereof, Consultant options to purchase 200,000 shares of common stock of the Company, with an
    exercise price of $1.75. “Options”). The Company shall provide Consultant with an Option Agreement, substantially
    in the form attached hereto as Exhibit D. 
	 	 	 
	 	○	Restricted
    Stock: : The Company shall grant, on the date hereof, Consultant 175,000 restricted shares of common stock of the Company (the
    “Restricted Shares”), subject to a milestone vesting schedule as set forth below:

 

	 	1.	75,000
    Restricted Shares shall vest upon the Company successfully listing its common stock on NASDAQ or the NYSE.
	 	2.	50,000
    Restricted Shares shall vest upon any Company financing after 1/1/2022 (of debt or equity) in which the gross proceeds equal
    or exceed $5,000,000.
	 	3.	25,000
    Restricted Shares shall vest upon the completion of valuation reports for both Somahlution LLC. and Health Logic Interactive
    Inc. 
	 	4.	25,000
    Restricted Shares shall vest upon a Material Commercial partnership for MATLOC. 

 

The
Company shall provide Consultant with a Restricted Stock Agreement, substantially in the form attached hereto as Exhibit E.

 

    	 

     

    

 

EXHIBIT
C

 

Warrant
Agreement

 

[See
Attached]

 

    	 

     

    

 

EXHIBIT
D

 

Option
Agreement

 

[See
Attached]

 

    	 

     

    

 

EXHIBIT
E

 

Restricted
Stock Agreement

 

[See
Attached]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]